Viruses and Human Leukemia in Vitro

  • Abraham Karpas
Chapter
Part of the Developments in Oncology Series book series (DION, volume 14)

Abstract

The search for a causative agent in the development of human leukemia is fueled by the overwhelming experimental evidence that retroviruses play a major role in the induction of leukemias in numerous animal species. Repeated efforts in laboratories in the United States and Europe to isolate a human retrovirus have failed so far. Expérimental animals were found to be unsuitable for the isolation of a human retrovirus mainly because most animal species carry their own retroviruses or because of the inability of a human leukemic virus, if such a virus exists, to cause leukemia in experimental animals.

Keywords

Acute Lymphoblastic Leukemia Rough Endoplasmic Reticulum Human Leukemia Mycosis Fungoides Rous Sarcoma Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bernhard W. The detection and study of tumor viruses with the electron microscope. Cancer Res 20:7 12–725, I960.Google Scholar
  2. 2.
    Gross L. “Spontaneous” leukaemia developing in C3H mice following inoculation, in infancy, with AK-leukemia extracts or AK-embryos. Prot Soc Exp Biol Med 76:27–32. 1951.Google Scholar
  3. 3.
    Jarrett WF, Martin WB, Crighton GW, Dalton RG. Stewart MF: Leukaemia in the cat: Transmission experiments with leukemia (lymphosarcoma). Nature 202: 566–567, 1964.PubMedCrossRefGoogle Scholar
  4. 4.
    Miller LD, Miller JM, Olson C. Inoculation of calves with particles resembling C-type virus from cultures of bovine lymphosarcoma. J Natl Cancer Inst 48: 423–428, 1972.PubMedGoogle Scholar
  5. 5.
    Kawakami TG. Huff SD. Buckley PM, Dangworth DL, Snyder SP, Gilden RV. C- type virus associated with Gibbon lymphosarcoma. Nature (New Biol) 235: 170–172, 1972.CrossRefGoogle Scholar
  6. 6.
    Temin HM. RNA-directed DNA svnthesis. Sei Am. 226: 24–33, 1972.Google Scholar
  7. 7.
    Svoboda J. Presence of chicken tumour virus in the sarcoma of the adult rat in-oculated with Rous sarcoma virus. Nature 186: 980–981, I960.Google Scholar
  8. 8.
    Hill M, Hillova J. Production virale dans les fibroblastes de poule traites par 1’acide deoxyribonucleic de cellules de rat XC translormces par le virus de Rous. C R Acad Sei (Paris) 272: 3094–3097, 1971.Google Scholar
  9. 9.
    Karpas A, Milstein C. Recovery of the genome of murine sarcoma virus lt;MSV) after infection of cells with nuclear DNA from MSV transformed non-virus- producing cells. Kur I Cancer 9: 295–299, 1973.Google Scholar
  10. 10.
    Karpas A, Tuckerman E. Transformation of human fibroblasts wirh DNA of cultured human rhabdomyosarcoma cells. Lancet 1: 1138–1141, 1974.PubMedCrossRefGoogle Scholar
  11. 11.
    Shih C, Padhy LC, Murray M. Weinberg RA. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261–264, 1981.PubMedCrossRefGoogle Scholar
  12. 12.
    Klein G: The role of gene dosage and genetic transpositions in carcinogenesis. Nature 294: 313–318, 1981.PubMedCrossRefGoogle Scholar
  13. 13.
    Schneider R. Human tancer in households containing cats wirh malignant lymphoma. Int J Cancer 10: 338–344, 1972.PubMedCrossRefGoogle Scholar
  14. 14.
    Gunz FW, Gunz JP, Vincent PC, Bcrgin M.Johnson RL. Bashir H. Kirk RL. Thirteen cases of leukemia in a family. J Natl Cancer Inst 60: 1243–1250. 1978.Google Scholar
  15. 15.
    Miller RW. Persons with exceptionally high risk of leukemia. Cancer Res 27: 2420–2423, 1967.PubMedGoogle Scholar
  16. 16.
    Fialkow PJ, Thomas ED. Bryant Jl, Neiman PE. Lcukaemic Transformation of engrafted human marrow cells in vivo. Lancet 1: 251–255, 1971.Google Scholar
  17. 17.
    Goh K. Klemperer MR In vivo leukemic transformation of engrafted marrow cells. Am J Hematol 2: 283–290, 1977.PubMedCrossRefGoogle Scholar
  18. 18.
    Karpas A. New virus expressed in cultured human leukaemic myeloblasts. Lancet: 110, 1978.Google Scholar
  19. 19.
    Karpas A, Fischer P. Ultrastructural expression of virus-like particles in human leukemic cells growing in vitro. Leuk Res 4: 315–329, 1980.PubMedCrossRefGoogle Scholar
  20. 20.
    Tanaka Y. Bell W. Brindley D. Pscudoviral inclusion bodies in acute leukemia A report of two cases. J Natl Cancer Inst 38: 629–635, 1967.PubMedGoogle Scholar
  21. 21.
    Sun CN. Brye GE. Pinkerton H. Virus-like particles in acute lymphoblastic leukaemia. Expericntia 29: 100–101, 1973.CrossRefGoogle Scholar
  22. 22.
    Berrebi A. Oberling A, Mayer S. Wairz R. Inclusions intracytoplasmic pseudovirales dans un cas de leukemic aigue lymphoide. Nouv Press Med 14: 897, 1974.Google Scholar
  23. 23.
    Sorenson GD Electron microscopic observations of viral particles within myeloma cells of man. Exp Cell Res 25: 219–224. 1961.PubMedCrossRefGoogle Scholar
  24. 24.
    Lejeune F, Turpin F. Lortholary P. Inclusions anormales dans les blastes d’une tranformation aigüe de leukémie myeloides chronique etude cytologique et ultrastructurale. Path Biol 26: 7–11. 1978.Google Scholar
  25. 25.
    Smith H. Inclusion bodies containing virus-like particles in acute lymphoblastic leukemia of childhood. Leuk Res 2: 133–140, 1978.CrossRefGoogle Scholar
  26. 26.
    Zavada J. Assay methods of viral pseudotypes. In: Maramorosch K. Koprowski H, eds. Methods in virology, vol 6. New York: Academic Press, 1977, pp. 109–142.Google Scholar
  27. 27.
    Karpas A, Wreghitr TG, Nagington J. Transformation of normal bone marrow cells by a leukaemic cell line associated wirh a presumptive new human virus. Lancet 2: 1016–1019, 1978.PubMedCrossRefGoogle Scholar
  28. 28.
    Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukaemia, clinical and haematological features of 16 cases. Blood 50: 481–492. 1977.PubMedGoogle Scholar
  29. 29.
    Hinuma Y. Nagata K. Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S, Miyoshi I. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78: 6476–6480, 1981.PubMedCrossRefGoogle Scholar
  30. 30.
    Reitz MS. Poiesz BJ. Ruscetti FW, Gallo RC. Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes. Proc Natl Acad Sci USA 78: 1887–1891. 1981.Google Scholar
  31. 31.
    Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, Gallo RC- Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T- cell leukaemia. Nature 294: 268–271, 1981.PubMedCrossRefGoogle Scholar
  32. 32.
    Yoshida M, Miyoshi 1, Hinuma Y. Isolation and characterisation of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79: 2031–2035, 1982.Google Scholar
  33. 33.
    Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y. Yukimasa S, Nagata K, Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukemic T cells. Nature 294: 770–771, 1981.PubMedCrossRefGoogle Scholar
  34. 34.
    Kalyanaraman VS. Sarngadharan MG. Bunn PA, MinnaJD. Gallo RC Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus. Nature 294: 271–273, 1981.Google Scholar
  35. 35.
    Oroszlan S. Sarngadharan MG, Copeland TD, Kalyanaraman VS, Gilden RV, Gallo RC. Primary structure analysis of the major internal protein p24 of human type C T- cell leukemia virus. Proc Nat Acad Sci USA 79: 1291–1294, 1982.PubMedCrossRefGoogle Scholar
  36. 36.
    Kalyanaraman VS, Sarngadharan MG. Poiesz BJ. Ruscitti FW, Gallo RC. Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J Virol 38: 906–916. 1981.PubMedGoogle Scholar
  37. 37.
    Pulvertaft RJV. Cytology of Burkitt’s tumour (African lymphoma). Lancet 1: 238 - 240, 1964.PubMedCrossRefGoogle Scholar
  38. 38.
    Epstein MA, Barr YM. Cultivation in vitro of human lymphoblasts from Burkitt’s malignant lymphoma. Lancet 1: 252–253, 1964.PubMedCrossRefGoogle Scholar
  39. 39.
    Henle G. Diehl V, Kohn G, zur Hausen H. Henle G. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157: 1064–1065. 1967.PubMedCrossRefGoogle Scholar
  40. 40.
    Pope JH, Hörne MK. Scott W. Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int I Cancer 3:857–866, 1968.Google Scholar
  41. 41.
    Henle G. Henle W, Diehl V. Relation of Burkitt’s tumor-associated herpes type virus to infectious mononucleosis. Proc Natl Acad Sci 59: 94–101, 1968.Google Scholar
  42. 42.
    Reedman BM, Klein G. Cellular localisation of an Epstein-Barr virus (EBV)- associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. Int I Cancer 11: 499–520. 1973.CrossRefGoogle Scholar
  43. 43.
    Zur Hausen H, Schulte-Holthausen H. Presence of EB virus nucleic acid in a virus-free line of Burkitt tumor cells. Nature 227: 245–248. 1970.PubMedCrossRefGoogle Scholar
  44. 44.
    Lenoir GM, Preud’homme JL, Bernheim A. Berger R. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt’s lymphoma. Nature 298: 474–476, 1982.PubMedCrossRefGoogle Scholar
  45. 45.
    Karpas A, Hayhoc FGJ, Grcenberger JS, Barker CR, Cawley JC, Lowcnthal RM, Moloney WC. The establishment and cytological, cytochemical and immunological characterisation of human haemiccell lines: Evidence for heterogeneity. Leuk Res 1: 35–49, 1977.CrossRefGoogle Scholar
  46. 46.
    Moore GE. Cultured human lymphocytes. J Surg Oncol 4: 320–353, 1972.PubMedCrossRefGoogle Scholar
  47. 47.
    Foley GE, Lazarus H, Färber S, Uzman BG, Boone BA, McCarthy RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18: 522–529, 1965.PubMedCrossRefGoogle Scholar
  48. 48.
    Minowada J, Ohuma T, Moore GE. Rosette-forming human lymphoid cell line: 1. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 49: 891–895, 1972.PubMedGoogle Scholar
  49. 49.
    Morikawa S. Tatsumi E. Baba M, Havada T, Yasuhiva K. Two E-rosette forming lymphoid cell lines. Int J Cancer 21: 166–170, 1978.PubMedCrossRefGoogle Scholar
  50. 50.
    Ravid Z, Goldblum N, Zaizov R. Schlesinger M, Kirtis T, Minowada J, Verbi W, Greaves M. Establishment and characterisation of a new leukemic T-cell line (PEFR) with an unusual phenotype. Int J Cancer 25: 705 - 710. 1980.PubMedCrossRefGoogle Scholar
  51. 51.
    Gillis S, Watson J. Biochemical and biological characterisation of lymphocyte regulating molecules: V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med 152: 1709–1719, 1980.Google Scholar
  52. 52.
    Poiesz DJ. Ruscitti FW. Gazdar AF. Bunn PA, Minna JD. Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sei 77: 7415–7149. 1980.Google Scholar
  53. 53.
    Poiesz BJ, Ruscitti FW, Reitz MS, Malyanaraman VS. Gallo RC. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia. Nature 294: 268–27 1, 1981.Google Scholar
  54. 54.
    Morgan DA. Ruscitti FW. Gallo RC. Selective in vitro growth of T-lymphocytes from normal human bone marrows. Science 193: 1007–1008, 1976.PubMedCrossRefGoogle Scholar
  55. 55.
    Boumsell L, Bernard A, Reinherz EL. Nadler LM, Ritz J, Coppin H, Richard Y, Dubertret L, Valensi F, Degos L. Lemerle J, Flandrin (j. Daussci J, Schlossman SF. Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood 57: 526–530. 1981.PubMedGoogle Scholar
  56. 56.
    Nilsson K, Sundström C. Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. Int J Cancer 13: 808–823, 1974.PubMedCrossRefGoogle Scholar
  57. 57.
    Klein G. Lindahl T. Jondal M, Lubold W, Menezes J, Nilsson K, Sundström C. Continuous lymphoid cell lines with characteristics of B cells (bone marrow-derived) lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sei USA 7 1 3283 - 3286, 1974.CrossRefGoogle Scholar
  58. 58.
    Hiraki S. Miyoshi I, Masuji Kubonishi I, Matsuda Y, Nakayama T. Kishimoto H. Chen P, Kimura I. Establishment of an Epstein-Barr virus-determined nuclear antigen-negative human B cell line from acute lymphoblastic leukemia: Brief communication. J Natl Cancer Inst 59: 93–94, 1977.PubMedGoogle Scholar
  59. 59.
    Lok MS, Koshiba H. Han T, Abe S, Minowada J, Sandberg AA. Establishment and characterisation of human B- lymphocytic lymphoma cell lines 8balm-3, -4, and -5) intraclonal variation in the B-cell differentiation stage. Int J Cancer 24: 572–578. 1979.PubMedCrossRefGoogle Scholar
  60. 60.
    Magrath IT, Pizzo PA. Whang-Peng J. Douglass EC, Alabaster O, Gerber P. Freeman CB, Novikovs L. Characterization of lymphoma-derived cell lines: Comparison of cell lines positive and negative for Epstein-Barr virus nuclear antisera: I. Physical, cytogenetic and growth characteristics. J Natl Cancer Inst 64: 465–476, 1980.PubMedGoogle Scholar
  61. 61.
    Karpas A, Sandler RM, Thorburn RJ. Null-cell properties of a lymphoid cell line from a child with acute lymphoblastic leukaemia. Br J Cancer 36: 17 7–186, 1977.Google Scholar
  62. 62.
    Rosenfelder C, Goutner A, Choquet C, Vinvat AM, Kayibada B, Pico JL, Greaves MF. Phenotypic characterisation of a unique non-T non-B ALL cell line. Nature 267: 841–843, 1977.CrossRefGoogle Scholar
  63. 63.
    Lazarus H, Barrell EF, Krishan A. Livingston PM, Harris K, Schlossman SF, Chess L. Characterisation of a unique cell line (LAZ 221) from human acute lymphocytic (null cell) leukemia Cancer Res 38: 1362–1367, 1978.PubMedGoogle Scholar
  64. 64.
    Nilsson K, Ponten J. Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 15: 321–341, 1975.PubMedCrossRefGoogle Scholar
  65. 65.
    Karpas A, Hayhoe FGJ, Greenberger J, Neumann H. Alkaline phosphatase in Epstein-Barr viral nuclear antigen-positive cell lines. Science 202: 318–319, 1978.PubMedCrossRefGoogle Scholar
  66. 66.
    Matsuoka Y, Moore GE, Yagi Y, Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med 125: 1246–1250, 1967.PubMedGoogle Scholar
  67. 67.
    Nilsson K, Bennick H, Johnsson SGO, Pontin J Established immunoglobulin producing myeloma (IgE) and Ivmphoblastoid cell lines from an IgE myeloma patient. Clin Exp Immunol 7: 477–489, 1968.Google Scholar
  68. 68.
    Togawa A, Inoue N, Miyamoto K. Hyodo H. Namba M. Establishment and characterisation of a human myeloma cell line (KMM-1) Int J Cancer 29: 495–500. 1982.PubMedCrossRefGoogle Scholar
  69. 69.
    Karpas A, Fischer P, Swirsky D. Human myeloma cell line carrying a Philadelphia chromosome. Science 216: 997–999, 1982.PubMedCrossRefGoogle Scholar
  70. 70.
    Karpas A, Fischer P. Swirsky, D. Human plasmacytoma with an unusual karyotype growing in vitro and producing light chain immunoglobulin. Lancet 1: 931–933, 1982.PubMedCrossRefGoogle Scholar
  71. 71.
    Lozzio CB, Lozzio BR. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45: 321–334, 1975.PubMedGoogle Scholar
  72. 72.
    Klein E, Ben-Bassat H, Neumann H. Ralph P. Ziuthen J. Polliack A. Vanky F. Properties of the K562 cell line derived from a patient with chronic myeloid leukemia. IncJ Cancer 18: 421–431, 1976.CrossRefGoogle Scholar
  73. 73.
    Koefller HP, Goide DW. Human myeloid leukaemia cell lines: A review. Blood 56: 344–350, 1980.Google Scholar
  74. 74.
    Andersson LC, Jokinen M, Gahmberg CG. Induction of erythroid differentiation in the human leukaemic cell line K562. Nature 278: 364–365, 1979.PubMedCrossRefGoogle Scholar
  75. 75.
    Sundström, C. Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17: 565–577, 1976.Google Scholar
  76. 76.
    Collins SJ. Gallo RC. Gallagher RE. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270: 347–349, 1977.PubMedCrossRefGoogle Scholar
  77. 77.
    Collins SJ, Ruscitti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocyte leukemia cells induced by dimethyl sulfoxide and other polar compounds Proc Natl Acad Sci USA 75: 2458–2462, 1978.PubMedCrossRefGoogle Scholar
  78. 78.
    Koeffler HP. Golde DW. Acute myelogenous leukaemia: A human cell line responsive ro colony-stimulating activity. Science 200: 1153–1154, 1978.PubMedCrossRefGoogle Scholar
  79. 79.
    Karpas A. Khalid G. Burns GF. Hayhoe FGJ. Continuous culture of malignant haemic cells from human acute myelomonocytic leukaemia. Cytological, cytochemical, cytogenetic and immunological studies. Br J Cancer 37: 308–315, 1978.PubMedCrossRefGoogle Scholar
  80. 80.
    Karpas A. Worman CP, Khalid G, Neumann H. Hayhoe FGJ, Newell D, Stewart JW. Phenotypic characterization of a virus producing line established from a patient with leukaemia/lymphoma: Comparison with T-lymphoblastic and myeloblasts lines. Br J Haematol 44: 415–424, 1980.PubMedCrossRefGoogle Scholar
  81. 81.
    Fischer P. Karpas A. Nacheva E, Haas O, Winterleither H, Krepler P. Characteristics of a cell line established from a child with familial acute myeloid leukaemia. Br J Haematol 46: 23–31, 1980.PubMedCrossRefGoogle Scholar
  82. 82.
    Tsuchiya S, Yamabe M, Yamaguchi Y. Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukaemia cell line (THP-1). Int J Cancer 26: 171–176, 1980.CrossRefGoogle Scholar
  83. 83.
    Martin P, Papayannopoulou T HEL cells: A new human erythroleukaemia cell line with spontaneous and induced globin expression. Science 216: 1233–1235, 1982.PubMedCrossRefGoogle Scholar
  84. 84.
    Newburger PE, Pagano JS, Greenberger JS, Karpas A, Cohen H. Dissociation of opsonized particle phagocytosis and respiratory burst activity m an Epstein-Barr virus-infected myeloid cell line. J Cell Biol 85: 549–557, 1980.PubMedCrossRefGoogle Scholar
  85. 85.
    Schaadt M, Diehl V, Stein H, Fonatsch C, Kirchner H. Two neoplastic cell lines with unique features derived from Hodgkin’s disease. Int J Cancer 26: 723–731, 1980.PubMedCrossRefGoogle Scholar
  86. 86.
    Golde DW. Quan SG. Cline MJ. Human T lymphocyte cell line producing colony-stimulating activity. Blood 52: 1068–1072, 1978.PubMedGoogle Scholar
  87. 87.
    Karpas A A human haemic cell line capable of cellular and humoral killing of normal and malignant cells. Br J Cancer 35: 152 - 160, 1977.PubMedCrossRefGoogle Scholar
  88. 88.
    Karpas A. A humoral cytotoxic substance produced by a human killer cell line. Br I Cancer 36: 437–445, 1977.CrossRefGoogle Scholar
  89. 89.
    Neumann H, Karpas A. Purification and physicochemical characterisation of a human cytotoxic factor produced by a human haemic cell line. Biochem J 194: 847–856, 1981.PubMedGoogle Scholar
  90. 90.
    Karpas A. Viruses and leukemia. Am Sci 70: 277–285, 1982.PubMedGoogle Scholar
  91. 91.
    Burk KH, Drewinko B, Trujillo JM. Ahearn MJ. Establishment of a human plasma cell line in vitro. Cancer Res 38: 2508–2511, 1978.PubMedGoogle Scholar
  92. 92.
    Edwards PAW: Some properties and applications of monoclonal antibodies. Biochem J 200: 1–10, 1981.PubMedGoogle Scholar
  93. 93.
    Haegert DG, Cawley JC, Karpas A, Goldtone AH. Combined T and B cell acute lymphoblastic leukemia. Bri Med I 4:79–84, 1974.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston/The Hague/Dordrecht/Lancaster 1984

Authors and Affiliations

  • Abraham Karpas

There are no affiliations available

Personalised recommendations